Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ROStrO-TMD: Oxidative Stress and Opiorphin in TMD
NCT03029494Unknown
- Sponsor
- Croatian Science Foundation
- Start
- Oct 2015
- Primary completion
- Sep 2018
- Countries
- 1
01
Overview
Randomised, double-blind trial (3 arms), sponsored by Croatian Science Foundation. Primary endpoint: Change of salivary oxidative stress markers concentration at 6 months. Status: unknown.
Beyond the preview
Go deeper on NCT03029494.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03029494.